Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Visiting Professor, Piet Bracke, Speaks on Public Mental Health
2015-02-20

Piet Bracke

Professor in the Department of Sociology at the Ghent University in Belgium, Piet Bracke, recently visited the UFS to speak about his research on the Public mental health and comparative health research: between social theory and psychiatric epidemiology.

At the public lecture on Monday 16 February, Bracke stated that part of the sociological attention to mental health and well-being was rooted in the 19th century's romanticists' discontent with self and society. The classical and contemporary social theorists' views on the disconnection between culture and the ‘real’ self resembles the more recent evolutionary psychological assumptions about the maladaptation of  psychobiological mechanisms to contemporary societal arrangements.

In contrast to these perspectives, contemporary psychiatric epidemiological research has a strongly underdeveloped conception about the nexus between society and population mental health. Both perspectives, the social-theory-and-societal-discontent approach and the biomedical psychiatric epidemiological approach, have drawbacks. Starting from the pitfalls of the aforementioned perspectives, they have been exploring the challenges posed by the development of a macro-sociology of population mental health.

Recently, this research domain has received renewed attention of scholars inside as well as outside sociology. The rise of multi-country, multilevel datasets containing health-related information, as well as the growing attention on the fundamental social causes of health and illness, and the focus on population as opposed to individual health, has contributed to the revival of comparative public mental health research. Based on findings from their recent research, they have illustrated how taking the context into account is vital when exploring the social roots of mental health and illness. In addition, they have demonstrated how they can liberate a few so-called ‘control variables’ in risk factor epidemiology – e.g. gender, education, and age – from their suppressed status by linking them to core concepts of sociology. With their research, they hope to further the development of a macro-sociology of public mental health.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept